David E. Gerber, MD, is a Professor of Internal Medicine and Population & Data Sciences at UT Southwestern Medical Center. Within the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, Dr. Gerber serves as Associate Director of Clinical Research. He is an active clinical investigator with more than 180 publications and continuous federal and foundation research funding for more than 10 years. In the area of cancer immunotherapy, Dr. Gerber has a particular interest in the impact of autoimmune comorbidities, the recognition and characterization of immune-related adverse events, and biomarkers for the prediction and diagnosis of these autoimmune toxicities.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more